Skip to main content
. 2013 Feb 28;8(2):e57430. doi: 10.1371/journal.pone.0057430

Figure 6. Effect of NPC delivery on EAE clincial features.

Figure 6

Intravenous delivery of control (light grey) and CD44-NPCs (dark grey) in the tail vein after disease onset significantly improves clinical features over sham (black) in EAE mice. While clinical signs reach a plateau more rapidly after the first peak in CD44-NPC treated animals differences in severity between control and CD44-NPCs are not observed.